KMR Group recently concluded an analysis spanning ten years, from 2005 to 2015, that evaluated cycle time performance for more than 17,000 interventional trials. The analysis investigates clinical trial differences by molecule type and shows an increase in both length...
Pearl Pathways is excited to announce the hiring of Michele Taylor as a regulatory compliance analyst. Taylor will help the Pearl team serve medical device and biopharmaceutical life science companies. Taylor brings 12 years of experience in Project Management in Life...
On November 22nd, Pearl Pathways COO, Gretchen Bowker, MS, RAC, FRAPS will lecture on the topic “Drug Development: Goin’ to the FDA” for the Indiana Clinical and Translational Sciences Institute (CTSI) Fall 2016 course – Tools and Techniques in Translational...
When you hear the term “App” in reference to an iPhone, iPad, or other smartphone/tablet devices, what pops into your head? If “Angry Birds” (a wildly popular downloadable game) or “Facebook” first comes to mind, then you haven’t been living in a dark,...
Pearl IRB’s very own Gretchen Bowker has been invited to speak at this year’s Regulatory Affairs Professionals Society (RAPS) annual meeting, which will be held at the Indiana Convention Center in Indianapolis from October 22nd to the 26th. RAPS is an...
